Baicalein, a novel anti-diabetic compound
Both in type 1 (T1D) and type 2 diabetes (T2D), the deterioration of glycemic control over time is primarily caused by an inadequate mass and progressive dysfunction of ?-cells, leading to the impaired insulin secretion. Thus, the search for agents to protect b-cell and enhance its function is impor...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
Virginia Tech
2017
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10919/76854 http://scholar.lib.vt.edu/theses/available/etd-08222012-020303/ |